DK0415766T3 - Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi - Google Patents

Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi

Info

Publication number
DK0415766T3
DK0415766T3 DK90309510.7T DK90309510T DK0415766T3 DK 0415766 T3 DK0415766 T3 DK 0415766T3 DK 90309510 T DK90309510 T DK 90309510T DK 0415766 T3 DK0415766 T3 DK 0415766T3
Authority
DK
Denmark
Prior art keywords
retinoids
induced skin
skin atrophy
glucocorticoid induced
reverse
Prior art date
Application number
DK90309510.7T
Other languages
Danish (da)
English (en)
Inventor
James A Mezick
Albert M Kligman
Robert J Capetola
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of DK0415766T3 publication Critical patent/DK0415766T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Pens And Brushes (AREA)
DK90309510.7T 1989-08-31 1990-08-30 Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi DK0415766T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/401,362 US5019569A (en) 1986-11-03 1989-08-31 Reversal of glucocorticoid-induced skin atrophy

Publications (1)

Publication Number Publication Date
DK0415766T3 true DK0415766T3 (da) 1997-01-27

Family

ID=23587438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90309510.7T DK0415766T3 (da) 1989-08-31 1990-08-30 Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi

Country Status (13)

Country Link
US (1) US5019569A (de)
EP (1) EP0415766B1 (de)
JP (1) JP3061628B2 (de)
AT (1) ATE147265T1 (de)
AU (1) AU634807B2 (de)
DE (1) DE69029625T2 (de)
DK (1) DK0415766T3 (de)
ES (1) ES2098253T3 (de)
GR (1) GR1000723B (de)
IE (1) IE903154A1 (de)
PT (1) PT95150B (de)
SG (1) SG50453A1 (de)
ZA (1) ZA906931B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
US5268176A (en) * 1991-07-22 1993-12-07 Avon Products, Inc. Method and compositions for the non-invasive treatment of telangiectasia
CZ188394A3 (en) * 1992-02-07 1996-02-14 Albert M Kligman Pharmaceutical preparation for the control of inflammatory dermatose cleaning and the use of corticosteroidal matter in combination with a retoidal matter for preparing such preparations
EP0659080B1 (de) * 1992-09-11 2001-07-11 BROWN, Sandra Verfahren zur behandlung von haarausfall
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
CA2129773C (en) 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
UA48212C2 (uk) * 1996-01-31 2002-08-15 Сергей Дмітрієвіч БУРЛАКОВ Антиглюкокортикоїдний лікарський засіб
FR2760362B1 (fr) * 1997-03-10 2000-08-11 Vitasterol Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles
US6008254A (en) 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
NO326950B1 (no) * 2006-09-20 2009-03-16 Pharma Medico Res Ltd Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
HUE050603T2 (hu) 2015-06-18 2020-12-28 Bausch Health Ireland Ltd Egy kortikoszteroidot és egy retinoidot tartalmazó topikális készítmények psoriasis kezelésére

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4126693A (en) * 1975-11-03 1978-11-21 Johnson & Johnson Retinoic acid derivatives in the treatment of acne
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
AU610587B2 (en) * 1987-04-06 1991-05-23 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid

Also Published As

Publication number Publication date
AU634807B2 (en) 1993-03-04
US5019569A (en) 1991-05-28
EP0415766A2 (de) 1991-03-06
ES2098253T3 (es) 1997-05-01
EP0415766A3 (en) 1992-04-08
JP3061628B2 (ja) 2000-07-10
ZA906931B (en) 1992-05-27
IE903154A1 (en) 1991-03-13
GR900100644A (en) 1991-12-30
SG50453A1 (en) 1998-07-20
DE69029625T2 (de) 1997-05-28
DE69029625D1 (de) 1997-02-20
ATE147265T1 (de) 1997-01-15
AU6198790A (en) 1991-03-07
GR1000723B (el) 1992-11-23
EP0415766B1 (de) 1997-01-08
PT95150B (pt) 1997-06-30
JPH03141218A (ja) 1991-06-17
PT95150A (pt) 1991-05-22

Similar Documents

Publication Publication Date Title
DK0415766T3 (da) Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi
ATE104845T1 (de) Tocopherolsorbat und entzuendungshemmende wirkstoffe enthaltende lichtschutzmittel.
ES553821A0 (es) Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
EP0266992A3 (de) Verhütung von glukocorticoid-induzierter Hautatrophie
DE69628448D1 (de) Transdermale verabreichungsform von flurbiprofen
FR2581542B1 (fr) Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
DK683987D0 (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
ES2101230T3 (es) Nuevos derivados de sustancias anti-inflamatorias, analgesicas y/o antipireticas no estereoideas, su uso y formulaciones farmaceuticas que las contienen.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ES2045484T3 (es) Nuevos derivados de la vitamina d: aplicaciones terapeuticas y a las dosificaciones de los metabolitos de la vitamina d.
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
DK627289D0 (da) Anvendelse af bicyclononanderivater
ATE87476T1 (de) Fluessige orale formulierung.
ATE104554T1 (de) Topische praeparate.
IT1231410B (it) Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
ATE137225T1 (de) Dihydrochinolin nmda antagonisten
IT1093342B (it) Dispositivo di azionamento lineare e la sua applicazione alla regolazione dell'angolo di sito dei proiettori di un veicolo
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
PT878195E (pt) Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
ES2125884T3 (es) Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa.
ATE17857T1 (de) Pharmazeutische praeparate enthaltend d-homo-4,17- androstadien-3-on.
ITMI930795A0 (it) Uso della midesteina come cicatrizzante e composizioni farmaceutiche topiche relative
BR1100204A (pt) Composição farmacêutica para tratar esquizofrenia
YU19292A (sh) Medicinski špric za jednokratnu upotrebu